Table of Contents
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL Submucosal injections MARKET, BY Type of Agent
6.1. Overview
6.2. Eleview and ORISE gel
6.3. Normal saline
6.4. Sextrose water
6.5. Hydroxyethyl Starch
6.6. Hydroxypropyl methylcellulose
6.7. Succinylated gelatin
6.8. Hyaluronic acid
6.9. Fibrinogen mixture
7. GLOBAL Submucosal injections MARKET, BY Application
7.1. Overview
7.2. Colorectal Cancer
7.3. Gastic Cancer
7.4. Esophageal Cancer
8. GLOBAL Submucosal injections MARKET, BY End User
8.1. Overview
8.2. Hospitals
8.3. Surgical Centers
8.4. Others
9. GLOBAL Submucosal injections MARKET, by Region
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. South Korea
9.4.5. Australia
9.4.6. Rest of Asia-Pacific
9.5. Rest of the World
9.5.1. Middle East
9.5.2. Africa
9.5.3. Latin America
10. Competitive Landscape
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Submucosal injections Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Submucosal injections Market,
10.7. Key developments and Growth Strategies
10.7.1. New Type of Agent Launch/Application Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. Company ProfileS
11.1. Seikagaku Corp
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Type of Agents Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Ovesco Endoscopy AG
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Type of Agents Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. GI Supply
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Type of Agents Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Cosmo Pharmaceuticals
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Type of Agents Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Boston Scientific
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Type of Agents Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. THE STANDARD
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Type of Agents Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Micro-Tech Endoscopy
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Type of Agents Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. ENDOCLOT PLUS, INC.
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Type of Agents Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
12. Appendix
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 Global Submucosal injections Market, Synopsis, 2018-2032
TABLE 2 Global Submucosal injections Market, Estimates & Forecast, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 6 North America Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 7 North America Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 8 North America Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 9 North America Submucosal injections MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 10 U.S. Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 11 U.S. Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 12 U.S. Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 13 Canada Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 14 Canada Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 Canada Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 16 Europe Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 17 Europe Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 18 Europe Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 19 Europe Submucosal injections MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 20 Germany Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 21 Germany Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 22 Germany Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 23 France Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 24 France Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 25 France Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 26 Italy Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 27 Italy Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 28 Italy Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 29 Spain Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 30 Spain Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 31 Spain Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 32 U.K Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 33 U.K Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 34 U.K Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 35 Rest of Europe Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 36 Rest of Europe Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 37 Rest of Europe Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 38 Asia Pacific Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 39 Asia Pacific Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 40 Asia Pacific Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 41 Asia Pacific Submucosal injections MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 42 Japan Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 43 Japan Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 44 Japan Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 45 China Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 46 China Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 47 China Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 48 India Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 49 India Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 50 India Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 51 Australia Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 52 Australia Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 53 Australia Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 54 south korea Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 55 south korea Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 56 south korea Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 57 Rest of asia-pacific Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 58 Rest of asia-pacific Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 59 Rest of asia-pacific Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 60 Rest of WOrld Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 61 Rest of WOrld Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 62 Rest of WOrld Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 63 Rest of WOrld Submucosal injections MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 64 Middle east Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 65 Middle east Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 66 Middle east Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 67 Africa Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 68 Africa Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 69 Africa Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 70 Latin america Submucosal injections MARKET, BY Type of Agent, 2018-2032 (USD BILLION)
TABLE 71 Latin america Submucosal injections MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 72 Latin america Submucosal injections MARKET, BY END USER, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global Submucosal injections Market
FIGURE 3 Market Dynamics for the Global Submucosal injections Market
FIGURE 4 Global Submucosal injections Market, Share (%), BY Type of Agent, 2022
FIGURE 5 Global Submucosal injections Market, Share (%), BY APPLICATION, 2022
FIGURE 6 Global Submucosal injections Market, Share (%), BY END USER, 2022
FIGURE 7 Global Submucosal injections Market, Share (%), by Region, 2022
FIGURE 8 north AMERICA: Submucosal injections MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 Europe: Submucosal injections MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Asia-Pacific: Submucosal injections MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 Rest of the world: Submucosal injections MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 Global Submucosal injections Market: Company Share Analysis, 2022 (%)
FIGURE 13 Seikagaku Corp: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 Seikagaku Corp: SWOT ANALYSIS
FIGURE 15 Ovesco Endoscopy AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 Ovesco Endoscopy AG: SWOT ANALYSIS
FIGURE 17 GI Supply: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 GI Supply: SWOT ANALYSIS
FIGURE 19 Cosmo Pharmaceuticals: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 Cosmo Pharmaceuticals: SWOT ANALYSIS
FIGURE 21 Boston Scientific.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 Boston Scientific.: SWOT ANALYSIS
FIGURE 23 THE STANDARD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 THE STANDARD: SWOT ANALYSIS
FIGURE 25 Micro-Tech Endoscopy: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 Micro-Tech Endoscopy: SWOT ANALYSIS
FIGURE 27 ENDOCLOT PLUS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 ENDOCLOT PLUS, INC.: SWOT ANALYSIS
